Navigation Links
FDA issues warnings on Three Popular Asthma drug labels

The U.S. Food and Drug Administration has updated the product labels for three widely known asthma drugs, which will now carry the warnings that the drugs may enhance // the risk of suffering a severe asthma attack that could also turn fatal.

The drugs that now carry the updated product labels will be the powerful bronchodilator medicines Advair and Serevent, made by GlaxoSmithKline Plc and Foradil from Novartis AG .The FDA has further advised that these inhaled drugs should only be used after other types of inhaled drugs like corticosteroids, have failed to alleviate the asthma attack.


'"/>




Page: 1

Related medicine news :

1. FDA issues warning for Droperidol
2. Psychiatric issues common in brain disease
3. Bone marrow stem cells may help repair cardiac tissues
4. Growing tissues
5. Adult Stem Cells From Fat Tissues For Healing
6. A Novel Method For Measuring Interstitial Fluid Pressure In Cancer Tissues
7. UCLA Researchers Transform Stem cells From Fat tissues Into Smooth Muscle
8. WHO issues Global Air Quality Guidelines
9. Hair-raising issues of hairdressers
10. Banking (T)issues : cloning issue surfaces
11. FDA warnings against use of antipsychotic drugs for elderly
Post Your Comments:
Breaking Medicine Technology:Veran Medical Receives FDA Clearance to Market Electromagnetic Navigated Bronchoscopy Product: The SPiN Drive(TM) System 2AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 2AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 3Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation 2Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation 3Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation 4Palomar Medical Reports Financial Results for Second Quarter 2009 53208 1Palomar Medical Reports Financial Results for Second Quarter 2009 53208 2Palomar Medical Reports Financial Results for Second Quarter 2009 53208 3Palomar Medical Reports Financial Results for Second Quarter 2009 53208 4Palomar Medical Reports Financial Results for Second Quarter 2009 53208 5Palomar Medical Reports Financial Results for Second Quarter 2009 53208 6Palomar Medical Reports Financial Results for Second Quarter 2009 53208 7Palomar Medical Reports Financial Results for Second Quarter 2009 53208 8Arena Pharmaceuticals to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference 53203 1Arena Pharmaceuticals to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference 53203 2Arena Pharmaceuticals to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference 53203 3Repligen Announces Conference Call of First Quarter Fiscal Year 2010 Results 13277 1Repligen Announces Conference Call of First Quarter Fiscal Year 2010 Results 13277 2Repligen Announces Conference Call of First Quarter Fiscal Year 2010 Results 13277 3